Stryker Corp., US8636671013

Stryker stock faces a rating split before October 29 results

Published on 10/03/2026 at 21:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Stryker stock carries a USD 420.00 RBC target after its October 1, 2026 Buy rating. Second-quarter revenue reached USD 6.59 billion, ahead of consensus.

Flatlay mit Aktienzertifikat, ISIN-Karte, Stethoskop und orthopädischem Implantatmodell
Flatlay-Arrangement mit Aktienzertifikat und ISIN-Karte US8636671013 illustriert eine Investition in Stryker Corp. Medizintechnik-Aktien, Illustration mit AI erstellt.

Stryker stock (ISIN US8636671013) was last at USD 275.43 on the NYSE on October 2, 2026 at 4:00 p.m. ET, up 0.90 percent from the prior close. The immediate catalyst is a fresh rating change: MarketBeat reported on October 3, 2026 that Wall Street Zen downgraded Stryker from Buy to Hold.

Analyst targets split at USD 420

The downgrade contrasts with RBC Capital's stance. As Markets Insider reported on October 2, 2026, RBC maintained a Buy rating and a USD 420.00 price target in a report released on October 1, 2026.

That target stands USD 144.57 above the October 2 price, which is 52.5 percent above the reference price. The contrast matters because the same report listed recent target reductions, including Stifel's cut to USD 330.00 from USD 360.00 and TD Cowen's reduction to USD 298.00 from USD 355.00.

Second-quarter figures set the benchmark

Stryker's second-quarter 2026 revenue was USD 6.59 billion, compared with consensus of USD 6.58 billion, while quarterly EPS was USD 3.69 against consensus of USD 3.49, according to MarketBeat in its October 3, 2026 report. Revenue was also 9.4 percent higher than in the same quarter a year earlier, giving investors a measurable operating cushion despite the rating split.

The next test is operational rather than purely technical. Barchart reported on October 1, 2026 that Stryker will host its third-quarter results webcast on October 29, 2026 at 4:30 p.m. ET. The release is scheduled for 4:05 p.m. ET that day.

Stock remains near yearly low

Stryker's October 2 reference price sat between a 52-week low of USD 267.00 and a high of USD 392.55. Its market capitalization was USD 105.6 billion, and trading volume reached 1,945,788 shares, putting the stock 29.8 percent below its yearly high.

Stryker Corporation stock data

  • Company: Stryker Corporation
  • ISIN: US8636671013
  • Ticker: SYK
  • Trading venue: NYSE
  • Price (as of October 2, 2026, 4:00 p.m. ET): USD 275.43
  • Market capitalization: USD 105.6 billion (as of October 2, 2026)
  • 52-week range: USD 267.00-392.55 (as of October 2, 2026)
  • Sector / Industry: Healthcare / Medical Equipment, Supplies and Distribution
  • Next earnings date: October 29, 2026

More news and analyses on Stryker stock

Disclaimer...

en | US8636671013 | STRYKER CORP. | boerse | 70221595 | bgmi